课题基金 / 基金详情

IRON-SIRR COREGULATION OF S.EPIDERMIDIS VIRULENCE

IRON-SIRR COREGULATION OF S.EPIDERMIDIS VIRULENCE
表皮葡萄球菌毒力的 IRON-SIRR 共调节
批准号:
6337869
负责人:
ROBERT JOSEPH HARRISON
金额:
$13.43万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2002-04-30

项目摘要

项目成果

ROBERT JOSEPH HARRISON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Iron is an important co-regulator of virulence in many bacterial species including Staphylococcus aurues and Staphylococcus epidermidis both significant human pathogens. The iron dependent transcriptional regulator DtxR [diphtheria toxin repressor] originally identified in Corynebacterium diphtheriae plays a critical role in virulence. DtxR functions as an iron sensor selectively silencing gene expression when iron is readily available. When iron levels become limiting the repressor dissociates and iron dependent genes are de-repressed. DtxR homologues can be identified in a number of gram positive pathogens including SirR in Staphylococcus epidermidis. While it is unlikely that all virulence determinants within a genera or specific species of bacteria are tied to one of these regulators it is reasonable to propose that a significant proportion rely on iron co-regulation of virulence. In Staphylococcus epidermidis both the uptake of iron from the environment and the production of bioflim appear to be at least partially regulated by the availability of iron. This proposal seeks to determine the feasibility of targeting the DtxR homologue SirR from Staphylococcus epidermidis as a potential drug target. PROPOSED COMMERCIAL APPLICATION: Direct application of existing primary to isolate iron independent SirR and test for alterations in virulence in S. epidermidis. Development of drug target to treat infections associated with medical devices. Percentage of annual $US6 billion antimicrobial drug market.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FATALITY ASSESSMENT AND CONTROL EVALUATION
  • 批准号:
    6941674
  • 项目类别:
  • 资助金额:
    $15.46万
  • 财政年份:
    2004
  • 负责人:
    ROBERT JOSEPH HARRISON
  • 依托单位:
Metal Repressor Targets and Peptide Activators
DEVELOPMENT OF A REPRESSOR BASED SCREEN FOR ANTIBIOTICS
海外基金